home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  September 30, 2016
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 689 active entries

Vybion, Inc.

33 Thornwood Dr.
Ithaca, NY 14850
United States of America, New York

Phone: 607-266-0860
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Description:

Vybion uses proprietary technologies to validate drug targets and develop therapeutic drugs for unmet needs.  INT41, an Intrabody disease modifying drug delivered as a Gene Therapy for the treatment of Huntington's disease (HD) a lethal neurodegenerative disease.   INT41 prevents oligomer and aggregate formation of mutant Huntingtin protein and gene dysregulation. Both cell-based and animal models have demonstrated efficacy and mechanism of action.  Other Intrabody programs are directed at precise targeting of protein-protein interactions coupled with gene expression profiling to identify and validate drug targets for subsequent small molecule discovery. 

Selected Categories:

Product Company   Service Company
Biopharma
- General

Last update of this entry: March 10, 2015

Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.